Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 4,000.00
-15.00 (-0.37%)
At close: May 13, 2025, 3:30 PM KST
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 309.67 billion as of May 13, 2025. Its market cap has increased by 20.11% in one year.
Market Cap
309.67B
Enterprise Value
383.18B
Revenue
3.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,000.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 309.67B, a decrease of -49.51%. That is a compound annual growth rate of -15.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 309.67B | -21.41% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 361.77T |
| SK hynix | 130.99T |
| LG Energy Solution | 74.41T |
| Samsung Biologics | 74.02T |
| Hyundai Motor Company | 41.61T |
| Hanwha Aerospace | 39.92T |
| HD Hyundai Heavy Industries | 36.66T |
| Kia Corporation | 35.16T |